This inventor holds 1 USPTO granted patent. Top assignee: Amcell Corporation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Wayne G. Godfrey: Innovator in Hematopoietic Stem Cell Research
Introduction
Wayne G. Godfrey is a notable inventor based in Atherton, California. He has made significant contributions to the field of hematopoietic stem cell research. His work focuses on the development of compositions that enhance the understanding and isolation of specific cell types.
Latest Patents
Wayne G. Godfrey holds a patent for a composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment. This invention provides compositions that specifically bind to the AC133 antigen, which is highly tissue-specific. The antigen is detected on a subset of hematopoietic progenitor and stem cells derived from various sources, including human bone marrow and cord blood. The specificity of the AC133 antigen makes it a valuable tool for isolating and characterizing human hematopoietic progenitor and stem cells.
Career Highlights
Wayne G. Godfrey is associated with Amcell Corporation, where he has contributed to advancements in stem cell research. His work has implications for both therapeutic applications and research methodologies in the field of hematology.
Collaborations
Wayne has collaborated with notable coworkers, including Amy H. Yin and Sheri Miraglia. Their combined efforts have furthered the understanding of hematopoietic stem cells and their applications.
Conclusion
Wayne G. Godfrey's innovative work in the field of hematopoietic stem cell research has led to significant advancements in the isolation and characterization of these vital cells. His contributions continue to impact the scientific community and pave the way for future research.